Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1230, 2000-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lenograstim + chemo for SCLC: cost effectiveness "finely balanced"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. :
Access to resources
Recommend
Irinotecan + carboplatin improves outcomes in SCLC
Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. :
Alefacept improves QOL in psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. :
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :